Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Oral Squamous Cell Carcinoma (OSCC)
Clinical trial register · China

Oral Squamous Cell Carcinoma (OSCC) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Shanghai 3
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai3
All 1 locations
Target enrolment
to

Oral Squamous Cell Carcinoma (OSCC) trials in China

3 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma
NCT07812467Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Shanghai Zhongshan Hospital
Phase 2
220
Shanghai
2026-10-01
Not yet open
Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07079410Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma, Resectable Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2025-07
Not yet open
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
NCT06728618Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC), Resectable Oral and Oropharyngeal Squamous Cell Carcinoma, Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
28
Shanghai
2024-12
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/condition/oral-squamous-cell-carcinoma-oscc

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies listing the condition Oral Squamous Cell Carcinoma (OSCC) that also match the filters currently applied.

How many Oral Squamous Cell Carcinoma (OSCC) trials are recruiting in China?

0 of the 3 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Oral Squamous Cell Carcinoma (OSCC)), 3 studies
PhaseStudiesRecruitingShare
Phase 230100%

Most active sponsors

Lead sponsors with the most studies (Oral Squamous Cell Carcinoma (OSCC))
Lead sponsorStudiesRecruiting
Shanghai Zhongshan Hospital30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.